搜尋結果
Why Weight-Loss Drugs Wegovy, Zepbound Are in Short Supply
Bloomberg· 5 小時前Have a confidential tip for our reporters? Shortages have left patients already on the ...
Ryan Garcia: What’s Ostarine And How Could A Boxer Use It To Cheat?
Forbes· 2 日前Ryan Garcia tested positive twice for the banned substance Ostarine the day before and the day ...
Wegovy, Mounjaro prices cut as British pharmacies compete for weight-loss patients
Reuters· 6 小時前Online pharmacies and slimming clinics are cutting prices for Wegovy and Mounjaro in Britain ...
Wegovy Is Available Again After Shortages, FDA Says—But Supplies Are Still Limited
Forbes· 3 日前The 1.7 milligram (mg) dose of Wegovy is listed as available on the FDA’s drug shortage ...
Novo Nordisk beats profit estimates as sales of weight loss drug Wegovy more than double ...
CNBC· 15 小時前Danish pharmaceutical giant Novo Nordisk, which became the most valuable company in Europe last ...
Amgen investors await weight-loss drug data
Reuters· 1 日前, opens new tab investors eyeing dramatic share price gains for rivals with successful obesity ...
Novo Trades at Hefty Discount to Lilly Even After 350% Rally
Bloomberg· 8 小時前... A/S’s more than 350% rally over the past four years may have further to run if the weight ...
Ozempic Maker Novo Nordisk Beats Profit Forecasts Amid Weight Loss Drug Frenzy
Forbes· 16 小時前Danish pharma giant Novo Nordisk raised its 2024 outlook and beat profit expectations in its first-quarter earnings Thursday ...
Novo Nordisk trims price for blockbuster obesity drug as competition heats up
Reuters· 6 小時前, opens new tab raised its 2024 outlook on Thursday as the Danish drugmaker races to boost ...
Weight-loss drug drives Eli Lilly to raise 2024 sales forecast by $2 billion
Reuters· 2 日前, opens new tab weight-loss drug Zepbound drove the company to raise its annual sales ... ...
weight loss 相關
廣告